SightfileU.S. market data from official filings
Companies › IMRN
IMMURON LTD (IMRN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001660046 · EDGAR filings · Updated 2026-07-27
IMMURON LTD (IMRN) has 7 institutional managers reporting positions valued at $65.7K per the latest 13F reporting period.
Institutional managers
7
Reported 13F value
$65.7K
Filings this week (1)
- 2026-07-27 — Foreign issuer report (6-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-21 — Foreign issuer report (6-K) filed
- 2026-07-20 — Foreign issuer report (6-K) filed
- 2026-07-16 — Foreign issuer report (6-K) filed
- 2026-07-06 — Foreign issuer report (6-K) filed
- 2026-06-29 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, IMMURON LTD has 7 institutional holders.
Related companies
NEXENTIS TECHNOLOGIES INC (NXTS) · Galmed Pharmaceuticals Ltd (GLMD) · AGAPE ATP CORP (ATPC) · GRI Bio Inc (GRI) · Adial Pharmaceuticals Inc (ADIL) · BGM Group Ltd (BGM)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.